Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Alpelisib
×
30 days
×
Clear all
Filters
3
NCT05022342
2026-02-23
SPEAR
Novartis
Completed
595 enrolled
NCT05038735
2026-02-20
EPIK-B5
Novartis
Phase 3
Active not recruiting
212 enrolled